| 論文種別 | その他 |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | A randomized phase III study of continuous maintenance bevacizumab with or without pemetrexed after induction therapy with carboplatin (Car), pemetrexed (Pem), and bevacizumab (Bev) for advanced non-squamous non-small cell lung cancer (nSQ-NSCLC) without sensitizing EGFR mutations: The COMPASS study (WJOG5610L). |
| 掲載誌名 | 正式名：Journal of clinical oncology 略 称：J Clin Oncol ISSNコード：0732183X/15277755 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 37(15),pp.S9003 |
| 著者・共著者 | Seto, T; Azuma, K; Yamanaka, T; Sugawara, S; Yoshioka, H; Ono, A; Atagi,
S; Iwamoto, Y; Hayashi, H; Okamoto, I; Saka, H; Shigeki, M; Fujimoto, D; Nishino, K; Horiike, A; Daga, H; Sone, T; Yamamoto, N; Nakagawa, K; Nakanishi, Y |
| 発行年月 | 2019/05 |
| 文献番号 | WOS:000487345806448 |